ACE2 and COVID-19: Angiotensin converting enzyme 2 (ACE2), through which SARS CoV-2 enters target cells, is only weakly expressed in monocytes (40), and the signal for their activation during SARS-CoV-2 infections is thought to originate from paracrine signaling of infected tissue.